{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:09:19Z","timestamp":1779174559301,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,11,22]],"date-time":"2008-11-22T00:00:00Z","timestamp":1227312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00277-008-0642-1","type":"journal-article","created":{"date-parts":[[2008,11,21]],"date-time":"2008-11-21T14:07:58Z","timestamp":1227276478000},"page":"639-645","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome"],"prefix":"10.1007","volume":"88","author":[{"given":"Kyung A.","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon-Goo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kihyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Hyeh","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Young","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Seog","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wooseong","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,22]]},"reference":[{"key":"642_CR1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 329:987\u2013994 doi: 10.1056\/NEJM199309303291402","journal-title":"N Engl J Med"},{"key":"642_CR2","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","volume":"104","author":"KA Blum","year":"2004","unstructured":"Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104:3009\u20133020 doi: 10.1182\/blood-2004-02-0405","journal-title":"Blood"},{"key":"642_CR3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00001622-200409000-00003","volume":"16","author":"YL Kasamon","year":"2004","unstructured":"Kasamon YL, Swinnen LJ (2004) Treatment advances in adult Burkitt lymphoma and leukemia. Curr Opin Oncol 16:429\u2013435 doi: 10.1097\/00001622-200409000-00003","journal-title":"Curr Opin Oncol"},{"key":"642_CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0002-9343(93)90174-N","volume":"94","author":"KR Hande","year":"1993","unstructured":"Hande KR, Garrow GC (1993) Acute tumor lysis syndrome in patients with high-grade non-Hodgkin\u2019s lymphoma. Am J Med 94:133\u2013139 doi: 10.1016\/0002-9343(93)90174-N","journal-title":"Am J Med"},{"key":"642_CR5","first-page":"50","volume":"17","author":"HH Hsu","year":"2004","unstructured":"Hsu HH, Chan YL, Huang CC (2004) Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: clinical features and therapeutic approach. J Nephrol 17:50\u201356","journal-title":"J Nephrol"},{"key":"642_CR6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0959-8049(05)80348-X","volume":"29A","author":"M Gasparini","year":"1993","unstructured":"Gasparini M, Rottoli L, Massimino M, Gianni MC, Ballerini E, Ravagnani F et al (1993) Curability of advanced Burkitt\u2019s lymphoma in children by intensive short-term chemotherapy. Eur J Cancer 29A:692\u2013698 doi: 10.1016\/S0959-8049(05)80348-X","journal-title":"Eur J Cancer"},{"key":"642_CR7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","volume":"85","author":"C Soussain","year":"1995","unstructured":"Soussain C, Patte C, Ostronoff M, Delmer A, Rigal-Huguet F, Cambier N et al (1995) Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85:664\u2013674","journal-title":"Blood"},{"key":"642_CR8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","volume":"87","author":"D Hoelzer","year":"1996","unstructured":"Hoelzer D, Ludwig WD, Thiel E, Gassmann W, L\u00f6ffler H, Fonatsch C et al (1996) Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 87:495\u2013508","journal-title":"Blood"},{"key":"642_CR9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00860936","volume":"9","author":"SL Saccente","year":"1995","unstructured":"Saccente SL, Kohaut EC, Berkow RL (1995) Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration. Pediatr Nephrol 9:569\u2013573 doi: 10.1007\/BF00860936","journal-title":"Pediatr Nephrol"},{"key":"642_CR10","first-page":"332","volume":"7","author":"SB Murphy","year":"1980","unstructured":"Murphy SB (1980) Classification, staging and end results of treatment of childhood non-Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7:332\u2013339","journal-title":"Semin Oncol"},{"key":"642_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127:3\u201311 doi: 10.1111\/j.1365-2141.2004.05094.x","journal-title":"Br J Haematol"},{"key":"642_CR12","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","volume":"97","author":"C Patte","year":"2001","unstructured":"Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, Lutz P, Coze C, Perel Y, Rapha\u00ebl M, Terrier-Lacombe MJ, Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique (2001) The Societe Francaise d\u2019Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97:3370\u20133379 doi: 10.1182\/blood.V97.11.3370","journal-title":"Blood"},{"key":"642_CR13","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/cncr.20143","volume":"100","author":"DA Rizzieri","year":"2004","unstructured":"Rizzieri DA, Johnson JL, Niedzwiecki D, Lee EJ, Vardiman JW, Powell BL et al (2004) Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251. Cancer 100:1438\u20131448 doi: 10.1002\/cncr.20143","journal-title":"Cancer"},{"key":"642_CR14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/1042819031000141301","volume":"45","author":"A Lacasce","year":"2004","unstructured":"Lacasce A, Howard O, Lib S, Fisher D, Weng A, Neuberg D et al (2004) Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity. Leuk Lymphoma 45:761\u2013767 doi: 10.1080\/1042819031000141301","journal-title":"Leuk Lymphoma"},{"key":"642_CR15","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","volume":"13","author":"GM Mead","year":"2002","unstructured":"Mead GM, Sydes MR, Walewski J, Grigg A, Hatton CS, Pescosta N, Guarnaccia C, Lewis MS, McKendrick J, Stenning SP, Wright D, UKLG LY06 collaborators (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt\u2019s lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 13:1264\u20131274 doi: 10.1093\/annonc\/mdf253","journal-title":"Ann Oncol"},{"key":"642_CR16","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1200\/JCO.2001.19.20.4014","volume":"19","author":"EJ Lee","year":"2001","unstructured":"Lee EJ, Petroni GR, Schiffer CA, Freter CE, Johnson JL, Barcos M et al (2001) Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of Cancer and Leukemia Group B Study 9251. J Clin Oncol 19:4014\u20134022","journal-title":"J Clin Oncol"},{"key":"642_CR17","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","volume":"17","author":"DA Thomas","year":"1999","unstructured":"Thomas DA, Cortes J, O\u2019Brien S, Pierce S, Faderl S, Albitar M et al (1999) Hyper-CVAD program in Burkitt\u2019s-type adult acute lymphoblastic leukemia. J Clin Oncol 17:2461\u20132470","journal-title":"J Clin Oncol"},{"key":"642_CR18","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/annonc\/mdi403","volume":"16","author":"M Divin\u00e9","year":"2005","unstructured":"Divin\u00e9 M, Casassus P, Koscielny S, Bosq J, Sebban C, Le Maignan C, Stamattoulas A, Dupriez B, Rapha\u00ebl M, Pico JL, Ribrag V, GELA, GOELAMS (2005) Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. Ann Oncol 16:1928\u20131935 doi: 10.1093\/annonc\/mdi403","journal-title":"Ann Oncol"},{"key":"642_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/1042819021000054661","volume":"44","author":"L Annemans","year":"2003","unstructured":"Annemans L, Moeremans K, Lamotte M, Garcia Conde J, van den Berg H, Myint H et al (2003) Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin\u2019s lymphoma in four European countries. Leuk Lymphoma 44:77\u201383 doi: 10.1080\/1042819021000054661","journal-title":"Leuk Lymphoma"},{"key":"642_CR20","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1542\/peds.82.6.863","volume":"82","author":"FB Stapleton","year":"1988","unstructured":"Stapleton FB, Strother DR, Roy S III, Wyatt RJ, McKay CP, Murphy SB (1988) Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma. Pediatrics 82:863\u2013869","journal-title":"Pediatrics"},{"key":"642_CR21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/039139880102400403","volume":"24","author":"HK Tan","year":"2001","unstructured":"Tan HK, Bellomo R, M\u2019Pis DA, Ronco C (2001) Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration. Int J Artif Organs 24:186\u2013191","journal-title":"Int J Artif Organs"},{"key":"642_CR22","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1345\/aph.1C336","volume":"37","author":"BT Yim","year":"2003","unstructured":"Yim BT, Sims-McCallum RP, Chong PH (2003) Rasburicase for the treatment and prevention of hyperuricemia. Ann Pharmacother 37:1047\u20131054 doi: 10.1345\/aph.1C336","journal-title":"Ann Pharmacother"},{"key":"642_CR23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-0609.2007.01013.x","volume":"80","author":"M Hummel","year":"2008","unstructured":"Hummel M, Reiter S, Adam K, Hehlmann R, Buchheidt D (2008) Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase. Eur J Haematol 80:331\u2013336 doi: 10.1111\/j.1600-0609.2007.01013.x","journal-title":"Eur J Haematol"},{"key":"642_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1592\/phco.27.1.111","volume":"27","author":"AR Sood","year":"2007","unstructured":"Sood AR, Burry LD, Cheng DK (2007) Clarifying the role of rasburicase in tumor lysis syndrome. Pharmacotherapy 27:111\u2013121 doi: 10.1592\/phco.27.1.111","journal-title":"Pharmacotherapy"},{"key":"642_CR25","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","volume":"97","author":"SC Goldman","year":"2001","unstructured":"Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL et al (2001) A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 97:2998\u20133003 doi: 10.1182\/blood.V97.10.2998","journal-title":"Blood"},{"key":"642_CR26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/sj.leu.2403566","volume":"19","author":"S Jeha","year":"2005","unstructured":"Jeha S, Kantarjian H, Irwin D, Shen V, Shenoy S, Blaney S et al (2005) Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial. Leukemia 19:34\u201338","journal-title":"Leukemia"},{"key":"642_CR27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bmt.1705379","volume":"37","author":"S Trifilio","year":"2006","unstructured":"Trifilio S, Gordon L, Singhal S, Tallman M, Evens A, Rashid K et al (2006) Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia. Bone Marrow Transplant 37:997\u20131001 doi: 10.1038\/sj.bmt.1705379","journal-title":"Bone Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0642-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-008-0642-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0642-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T06:56:39Z","timestamp":1684652199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-008-0642-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,22]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1007\/s00277-008-0642-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,22]]}}}